Last Updated: May 10, 2026

Drugs Containing Excipient (Inactive Ingredient) PROPYLENE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PROPYLENE excipient, and estimated key patent expiration / generic entry dates

Company Tradename Ingredient NDC Excipient Potential Generic Entry
LEO Pharma Inc PROTOPIC tacrolimus 50222-203 PROPYLENE CARBONATE
Physicians Total Care Inc PROTOPIC tacrolimus 54868-5233 PROPYLENE CARBONATE
Acrotech Biopharma Inc DIFAMILAST adquey 72893-017 PROPYLENE CARBONATE 2036-12-31
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Market Dynamics and Financial Trajectory for Propylene in Pharmaceutical Excipients

Last updated: February 21, 2026

What Is Propylene and Its Role in Pharmaceutical Excipients?

Propylene (C3H6) is a colorless gas at room temperature. It is classified as a propene and is produced via steam cracking of hydrocarbons. In pharmaceutical applications, propylene is primarily used as an intermediate in the manufacture of polypropylene, which functions as an excipient or packaging material. It is also involved in producing polyvinyl chloride (PVC), which serves as capsules, containers, or delivery devices in drug formulations.

Market Drivers for Propylene in Pharmaceutical Applications

Increasing Demand for Polypropylene and PVC

Polypropylene (PP) and PVC are among the most widely used plastics in medical devices, packaging, and drug delivery systems. The global polypropylene market reached approximately USD 125 billion in 2022, with a compound annual growth rate (CAGR) of 4.1% from 2017 to 2022[1]. The growth stems from their stability, chemical resistance, and cost-effectiveness.

Expansion of the Pharmaceutical Industry

The pharmaceutical industry is expanding at a CAGR of 6.3%, projected to reach USD 1.7 trillion by 2027[2]. This expansion increases demand for pharmaceutical excipients, particularly those derived from propylene, like polypropylene containers and PVC-based drug delivery systems.

Regulatory and Safety Standards

Stringent safety standards favor the use of well-established, chemically stable polymers like polypropylene and PVC. Their biocompatibility and inertness reduce contamination risk, which enhances their adoption for pharmaceutical applications.

Key Market Segments

Segment Key Application Market Share (2022) CAGR (2022-2027)
Medical Device Manufacturing Syringes, containers, inhalers 45% 5.2%
Packaging Blister packs, bottles, caps 35% 3.8%
Drug Delivery Systems Controlled-release capsules, transdermal patches 20% 4.5%

Regional Market Dynamics

  • North America: Largest market, driven by high healthcare expenditure ($11,582 per capita in 2022[3]) and stringent safety protocols. The US accounts for 60% of regional demand.
  • Asia-Pacific: Rapidly growing, with a CAGR of 6.8% due to expanding healthcare infrastructure and manufacturing facilities in China and India.
  • Europe: Mature market with steady demand; regulations favor established polymers.

Production and Supply Chain Considerations

Global propylene supply is sensitive to upstream hydrocarbon prices and refinery operations. Key producers include ExxonMobil, LyondellBasell, and Sinopec. Market stability is influenced by:

  1. Oil price fluctuations.
  2. Capacity additions or reductions.
  3. Trade policies and tariffs.

The supply chain for pharmaceutical excipients is relatively resilient, but disruptions can affect pricing and availability, impacting manufacturers' margins.

Financial Trajectory and Investment Outlook

Spot and Contract Prices

Propylene prices have exhibited volatility, with prices ranging between USD 850 and USD 1,200 per metric ton in 2022[4], influenced by crude oil prices and supply-demand imbalances.

Investment Trends

  • Refinery capacities are increasingly integrated with petrochemical complexes, boosting propylene production.
  • Companies are investing in green technologies to produce bio-based propylene derivatives, aligning with sustainability goals.

Profitability Metrics

  • Gross margins for polypropylene producers hovered around 15-20% in 2022.
  • Downstream pharmaceutical packaging units enjoy margins of 10-15%, with stability due to contractual supply agreements.

Future Outlook

The market is expected to maintain a CAGR of 4-5% from 2023 to 2027, with growth driven by the rising need for safe, reliable pharmaceutical packaging materials. Advancements in bio-based propylene could open new avenues, albeit with initial R&D costs.

Regulatory Factors & Market Barriers

Regulatory Compliance

ISO standards for medical plastics and FDA approvals govern the use of polypropylene and PVC in pharmaceutical applications. Compliance increases production costs but enhances market access.

Environmental Concerns

Environmental regulations targeting plastic waste could limit disposable plastics' use, pushing manufacturers toward recyclable or biodegradable alternatives.

Competitive Landscape

Company Market Share Key Strategies
ExxonMobil 20% Capacity expansion and R&D in bio-based propylene production
LyondellBasell 18% Diversification into specialty polymers for pharma applications
Sinopec 12% Focus on Asia-Pacific growth and environmentally friendly processes

Key Takeaways

  • Propylene is crucial in manufacturing polypropylene and PVC, fundamental in pharmaceutical excipients.
  • Market growth aligns with pharmaceutical expansion, especially in emerging markets.
  • Price volatility remains a concern, contingent on crude oil prices and capacity dynamics.
  • Environmental policies could influence future demand, emphasizing sustainability.
  • Key players invest in capacity growth and green production methods to secure market positioning.

FAQs

1. How does crude oil pricing impact propylene markets?
Crude oil prices directly influence refinery margins and, consequently, the cost of propylene. Lower oil prices typically reduce feedstock costs, decreasing propylene prices. Conversely, rising oil prices inflate costs, affecting downstream product margins.

2. What are the main regulatory challenges for propylene used in pharmaceuticals?
Regulations focus on ensuring biocompatibility, chemical safety, and environmental impact. Compliance with ISO and FDA standards increases costs but is necessary for market access.

3. Are bio-based propylene derivatives gaining market share?
Yes. Companies like Braskem and Total are investing in bio-propylene, which is produced from renewable feedstocks like sugar or biomass. These are viewed favorably by environmentally conscious markets.

4. How does regional demand vary for pharmaceutical propylene products?
North America leads due to advanced healthcare infrastructure. Asia-Pacific's rapidly expanding pharmaceutical manufacturing sector drives regional growth. Europe maintains steady demand, with increasing focus on sustainability.

5. What are potential risks to market stability?
Risks include oil price fluctuations, trade tariffs, oversupply from capacity expansions, and regulatory shifts favoring biodegradable plastics. Supply chain disruptions due to geopolitical issues can also impact availability and pricing.


References

[1] Grand View Research. (2023). Polypropylene Market Size, Share & Trends Analysis.
[2] Research and Markets. (2022). Global Pharmaceutical Industry Outlook.
[3] World Bank. (2022). Healthcare Expenditure Per Capita.
[4] ICIS Chemical Business. (2022). Propylene Price Report.

[1] APA citation style sources listed for reference.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.